D Stoppa-Lyonnet Selected Research

D Stoppa-Lyonnet Research Topics

9	Neoplasms (Cancer) 08/2021 - 01/2000
5	Ovarian Neoplasms (Ovarian Cancer) 04/2018 - 05/2001
4	Breast Neoplasms (Breast Cancer) 07/2009 - 11/2000
2	Uveal melanoma 12/2010 - 02/2000
2	Retinoblastoma (Glioblastoma, Retinal) 12/2001 - 02/2000
1	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2017
1	autosomal recessive 1 Spinocerebellar ataxia 11/2017
1	Ataxia (Dyssynergia) 11/2017
1	Apraxias (Dyspraxia) 11/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2010
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2010
1	Amyloid Neuropathies (Amyloid Neuropathy) 07/2009
1	Prostatic Neoplasms (Prostate Cancer) 07/2008
1	Chromosome Breakage 01/2005
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2003
1	Genomic Instability 12/2001
1	Carcinogenesis 11/2001
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2001
1	Melanoma (Melanoma, Malignant) 02/2000
1	Cutaneous Malignant Melanoma 02/2000

3	DNA (Deoxyribonucleic Acid)IBA 04/2018 - 06/2001
3	Biological ProductsIBA 10/2010 - 11/2000
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2017 - 01/2005
2	Tumor Suppressor Protein p14ARF (p14ARF)IBA 12/2010 - 02/2000
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2010
1	Prealbumin (Transthyretin)IBA 07/2009
1	Proteins (Proteins, Gene)FDA Link 10/2006
1	Codon (Codons)IBA 06/2006
1	UbiquitinIBA 11/2001
1	Apoptosis Regulatory ProteinsIBA 11/2001
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2001
1	Aligeron (AS 2)IBA 05/2001
1	Estrogens (Estrogen)FDA Link 12/2000
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2000
1	Tamoxifen FDA LinkGeneric 12/2000
1	Cyclin-Dependent Kinase 4IBA 02/2000

3	Drug Therapy (Chemotherapy) 07/2008 - 12/2000
1	Immunotherapy 08/2021
1	Genomic Medicine 10/2010
1	Precision Medicine 01/2006
1	Prophylactic Surgical Procedures 01/2006
1	Radiotherapy 12/2001
1	Ovariectomy (Oophorectomy) 12/2000
1	Prophylactic Mastectomy 01/2000